Loading clinical trials...

Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes

Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes; A Proof-of-concept, Randomized, Double-blind, Parallel-group Placebo-controlled Study

NCT01964703•Korea University Anam Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether Rubus occidentalis extract could improve fasting or postprandial serum glucose levels, and related metabolic markers among patients with prediabetes (impaired fasting glucose and/or impaired glucose tolerance).

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•19 years of age or older
•prediabetes (fasting plasma glucose 100-125mg/dl, and/or post 75g OGTT plasma glucose 140-199mg/dl)

Exclusion Criteria

•pregnant women
•taking anti-hyperglycemic agents within 3 months at the time of enrollment
•history of heart failure, myocardial infarction, cerebral infarction
•uncontrolled hypertension (systolic BP \> 160mmHg, or diastolic BP \> 100mmHg)
•serum triglyceride level \> 500mg/dl
•kidney dysfunction (serum Creatinine \> 30% of upper normal limits)
•hepatic dysfunction (AST, ALT \> 3 times of upper normal limits)
•taking systemic glucocorticoids within 1 month

Key Dates

Start Date

April 1, 2013

Primary Completion Date

October 1, 2013

Last Updated

October 17, 2013

Enrollment

ACTUAL participants

Conditions

Prediabetes (Impaired Fasting Glucose and/or Impaired Glucose Tolerance)

Interventions

Rubus occidentalis extract

DRUG